Pages that link to "Q38323769"

The following pages link to Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events (Q38323769):

Displaying 46 items.

• Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells (Q28368229) (← links)
• 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication (Q31372299) (← links)
• Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. (Q33391858) (← links)
• Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice (Q33851826) (← links)
• Doxorubicin, DNA torsion, and chromatin dynamics (Q34039414) (← links)
• Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? (Q34102834) (← links)
• Catalytic topoisomerase II inhibitors in cancer therapy. (Q35187762) (← links)
• Amsacrine as a Topoisomerase II Poison: Importance of Drug–DNA Interactions (Q35788447) (← links)
• Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events (Q36379849) (← links)
• TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma (Q37188707) (← links)
• Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha (Q37323539) (← links)
• Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanism (Q38288542) (← links)
• Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage (Q38335859) (← links)
• DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs (Q38344294) (← links)
• Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides (Q38363278) (← links)
• Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria (Q39398757) (← links)
• The periodontal pathogen Porphyromonas gingivalis induces the Epstein–Barr virus lytic switch transactivator ZEBRA by histone modification (Q39426632) (← links)
• Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (Q40476934) (← links)
• The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II. (Q40573727) (← links)
• Synthesis and antiproliferative activity of basic thioanalogues of merbarone (Q40646513) (← links)
• Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells (Q40694343) (← links)
• Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes (Q40694350) (← links)
• S16020–2, a New Highly Cytotoxic Antitumor Olivacine Derivative: DNA Interaction and DNA Topoisomerase II Inhibition (Q41060407) (← links)
• Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16. (Q41504857) (← links)
• DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide (Q41628855) (← links)
• Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time (Q41788182) (← links)
• Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L. (Q41840140) (← links)
• Topoisomerase IV catalysis and the mechanism of quinolone action (Q47891380) (← links)
• Azatoxin Is a Mechanistic Hybrid of the Topoisomerase II-Targeted Anticancer Drugs Etoposide and Ellipticine (Q52586384) (← links)
• Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288). (Q54030192) (← links)
• A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine. (Q54182306) (← links)
• A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex. (Q55021320) (← links)
• Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I (Q70915257) (← links)
• In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin (Q72711259) (← links)
• Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone (Q73011661) (← links)
• Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy (Q73039468) (← links)
• F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action (Q73551252) (← links)
• Genotoxicity of several clinically used topoisomerase II inhibitors (Q74038020) (← links)
• Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardioprotectors and antitumor drugs (Q74619827) (← links)
• Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme (Q77333661) (← links)
• Catalytic inhibitors of DNA topoisomerase II (Q77333673) (← links)
• Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone (Q78020880) (← links)
• Topoisomerase II inhibitors (Q80510502) (← links)
• Topoisomerase II inhibitors (Q81086247) (← links)
• Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression (Q83607231) (← links)
• Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients (Q91773870) (← links)